Administrators of the Tulane Educational Fund v. Biomeasure, Inc.
District Court, E.D. Louisiana
1Opinion of the Court
ORDER AND REASONS
SARAH S. VANCE, District Judge.
Before the Court are Ipsen S.A. (“Ipsen”)’s and Ipsen Pharma, S.A.S. (“Ipsen Pharma”)’s motions to dismiss plaintiffs’ complaint under Federal Rule of Civil Procedure 12(B)(2). 1 (R. Docs. 18, 24, 38.)
I. BACKGROUND
This dispute involves the rights to a drug named Taspoglutide, or BIM-51077. Plaintiffs, Tulane University and Dr. Coy, assert that BIM-51077 was developed as part of a joint research program between Tulane, Dr. David Coy, and Biomeasure, Inc. (“Biomeasure”). This research was conducted under the terms of an Amended and Restated…
2Cases cited19 opinions
- International Shoe Co. v. WashingtonSupreme Court of the United States · 1945
- World-Wide Volkswagen Corp. v. WoodsonSupreme Court of the United States · 1980
- Helicopteros Nacionales De Colombia, S. A. v. HallSupreme Court of the United States · 1984
- Insurance Corp. of Ireland v. Compagnie Des Bauxites De GuineeSupreme Court of the United States · 1982
- Perkins v. Benguet Consolidated Mining Co.Supreme Court of the United States · 1952
14 more not listed; retrieve them via the Exa API.
3Cited by7 opinions
- Administrators of the Tulane Educational Fund v. Ipsen Pharma, S.A.S.District Court, District of Columbia · 2011
- In Re Chinese Manufactured Drywall Products Liab.District Court, E.D. Louisiana · 2011
- Pate v. American International Specialty Lines InsuranceDistrict Court, E.D. Louisiana · 2011
- Administrators of the Tulane Educational Fund v. Ipsen Pharma, S.A.S.District Court, District of Columbia · 2011
- Bertram v. Progressive Southeastern Insurance CoDistrict Court, W.D. Louisiana · 2023
2 more not listed; retrieve them via the Exa API.